Dynein Motor Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Dynein Motor Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Dynein is a large motor protein complex that moves along microtubules toward the minus end (retrograde transport). It is essential for intracellular transport, organelle positioning, and cell division.
- DYNC1H1: Heavy chain 1
- DYNLT1: Light chain
- DYNLRB1: Roadblock light chain
- DYNLL1: LC8 light chain
- Outer arm: Fast movement
- Inner arm: Controlled movement
- Motor domain: ATPase activity
- Microtubule-binding domain: Binds MTs
- Stalk domain: Coiled-coil structure
- Tail domain: Cargo binding
- Dynactin: Enhances processivity
- BICD: Cargo adaptor
- Rab proteins: Membrane cargo
- Retrograde axonal transport: Carries cargo toward cell body
- Organelle positioning: Endosomes, lysosomes
- Mitochondrial distribution: Alters mitochondrial dynamics
- Nuclear migration: Positioning in neurons
- Spindle assembly: Centrosome separation
- Chromosome congression: Aligns chromosomes
- Anaphase movement: Segregation
- Tau pathology: Disrupts dynein function
- Axonal transport deficits: Early event
- Retrograde signaling: Impaired
- LRRK2 mutations: Affect dynein regulation
- Alpha-synuclein: May impair transport
- Mitochondrial dysfunction: Transport deficits
- Huntingtin mutations: Disrupt dynein function
- BDNF transport: Impaired retrograde
- Cargo transport: General deficits
- DYNC1H1 mutations: Cause motor neuron disease
- Dynactin defects: Impaired transport
- Axonal transport: Primary pathology
- Microtubule stabilizers: Improve transport
- Dynein activators: Enhance function
- Dynactin enhancers: Increase processivity
- Cargo-specific targeting: Selective delivery
Dynein Motor Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Dynein Motor Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Vallee RB, et al. (2001). Cytoplasmic dynein and dynactin. Methods Cell Biol. PMID:11522079.
- Karki S, Holzbaur EL. (1999). Cytoplasmic dynein and dynactin in cell division and intracellular transport. Curr Opin Cell Biol. PMID:10089350.
- Hirokawa N. (1998). Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science. PMID:9641913.
- Chevalier-Larsen E, Holzbaur EL. (2006). Axonal transport in neurodegenerative disease. Biochim Biophys Acta. PMID:16806089.
- Reed NA, et al. (2006). Microtubule acetylation promotes dynein function. Curr Biol. PMID:16678099.
- Lenz ML, et al. (2006). Myosin vs. dynein: motor function in axonal transport. Cell. PMID:16407980.
- Ha J, et al. (2021). Dynein mutations in neurodegenerative disease. J Cell Biol. PMID:34081158.
- Lipka J, et al. (2013). Human cytoplasmic dyneins. Nat Rev Neurosci. PMID:23591973.
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
8 references |
| Replication |
0% |
| Effect Sizes |
25% |
| Contradicting Evidence |
0% |
| Mechanistic Completeness |
50% |
Overall Confidence: 29%